markets

Cboe Backs Legal Challenge to CFTC Single-Stock Perpetual Derivatives Approval

Summarized from All Financial Services & Investing

Cboe Global Markets has joined the Capital Markets Alliance in a lawsuit challenging the CFTC's approval of single-stock perpetual derivatives contracts.

Cboe Backs Legal Challenge to CFTC Single-Stock Perpetual Derivatives Approval

Cboe Global Markets announced support Monday for legal action brought by the Capital Markets Alliance targeting a regulatory decision by the Commodity Futures Trading Commission to approve single-stock perpetual derivatives, a relatively novel class of financial instruments that has drawn scrutiny from established exchange operators.

The Chicago-based exchange giant issued a formal statement aligning itself with the CMA's challenge, signaling that major incumbent players in the equity and index derivatives space view the CFTC's move as a significant regulatory boundary question. Cboe, which describes itself as a pioneer in equity and index derivatives, has a direct competitive and structural interest in how such products are classified and overseen.

Read more Marathon Petroleum Posts $7.4B Net Income in Third Quarter 2026 →

Single-stock perpetual derivatives — contracts with no fixed expiration date tied to individual equities — have been associated with crypto-adjacent trading platforms seeking to expand into traditional securities-linked instruments. Their approval by the CFTC raises jurisdictional questions about whether such products belong under futures regulation or fall within the purview of securities law overseen by the SEC.

The Capital Markets Alliance's lawsuit reflects broader industry tension over regulatory arbitrage, where novel product structures may allow issuers to sidestep oversight frameworks that apply to comparable instruments on legacy exchanges. By lending its name to the challenge, Cboe amplifies institutional pressure on the CFTC to revisit or more rigorously justify its approval pathway for the products.

The outcome of the legal challenge could have lasting implications for how derivative instruments are classified across U.S. financial markets and which regulator holds primary authority over emerging contract structures. Continue reading at All Financial Services & Investing.

Frequently Asked Questions

Q.What are single-stock perpetual derivatives?

Single-stock perpetual derivatives are contracts with no fixed expiration date that are tied to individual equities. They have drawn regulatory scrutiny as a novel instrument seeking CFTC approval.

Q.Why is Cboe opposing the CFTC's approval of these derivatives?

Cboe issued a statement supporting the Capital Markets Alliance's legal challenge, suggesting the exchange views the CFTC's approval as raising significant regulatory and competitive concerns for established derivatives markets.

Q.Who is the Capital Markets Alliance and what is it challenging?

The Capital Markets Alliance is an industry group that has filed legal action against the CFTC's decision to approve single-stock perpetual derivatives, with Cboe Global Markets publicly backing the challenge.

More in markets →